Taiwan FDA registration 29af1d3962a888be7f4963a5f742582e
Jinquan 2365 blood glycoreaction membrane
TW: 金泉 2365血醣反應膜
Taiwan·Risk Class 2·YSI INCORPORATED·Registered Dec 13, 2005 – Dec 13, 2015CancelledRegistration details
- Analysis ID
- 29af1d3962a888be7f4963a5f742582e
- Customs Code
- DHA00601553902
Company information
- Manufacturer
- YSI INCORPORATED
- Manufacturer Country
- United States
- Authorized Representative
- BIOLINK SCIENTIFIC INC.
Product details
- Intended Use
- Using YSI's patented solidified per-electrode technology, the glucose content in the blood is measured.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1345 Glucose Test System
- Import Information
- import
Dates and status
- Registration Date
- Dec 13, 2005
- Expiry Date
- Dec 13, 2015
- Cancellation Date
- Jun 25, 2018
Cancellation information
- Status
- Logged out
- Reason
- 許可證已逾有效期
About this record
Access comprehensive regulatory information for Jinquan 2365 blood glycoreaction membrane in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 29af1d3962a888be7f4963a5f742582e and manufactured by YSI INCORPORATED. The authorized representative in Taiwan is BIOLINK SCIENTIFIC INC..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices